Literature DB >> 19050892

Increased apoptosis in circulating lymphocyte cultures of anti-RNA polymerase III positive patients with systemic sclerosis.

Franca Majone1, Silvia Olivieri, Franco Cozzi, Anna Montaldi, Marta Tonello, Maria Serena Visentin, Luca Ciprian, Amelia Ruffatti.   

Abstract

The sera of 39 patients (38 women and 1 man), 16 with limited and 23 with diffuse clinical form of systemic sclerosis (SSc), were tested for anti-centromere (ACA), anti-topoisomerase I (ATA) and anti-RNA polymerase III (ARA) antibodies. The presence of apoptotic cells in cultures of circulating lymphocytes was investigated using the TUNEL (terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling) technique. ACAs were present in 16 (41%), ATA in 15 (38%) and ARA in 8 (21%) cases. The mean frequency of apoptotic lymphocytes was statistically higher in the ARA positive patients with respect to that in the control population (P < 0.001), in ACA (P < 0.001) and in the ATA (P < 0.001) groups. Moreover, apoptosis was distributed homogenously in ACA and ATA positive subjects, but not in the ARA patients. Our results show that there is an increase in apoptosis in the lymphocytes of ARA positive SSc patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19050892     DOI: 10.1007/s00296-008-0799-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  18 in total

1.  Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.

Authors:  Paola Cipriani; Antonietta Fulminis; Elisa Pingiotti; Alessandra Marrelli; Vasiliki Liakouli; Roberto Perricone; Alberto Pignone; Marco Matucci-Cerinic; Roberto Giacomelli
Journal:  J Rheumatol       Date:  2006-10       Impact factor: 4.666

Review 2.  Antinuclear antibody in systemic sclerosis (scleroderma).

Authors:  Y Okano
Journal:  Rheum Dis Clin North Am       Date:  1996-11       Impact factor: 2.670

3.  Induction of micronuclei by mitomycin C and colchicine in the marine mussel Mytilus galloprovincialis.

Authors:  F Majone; R Brunetti; O Fumagalli; M Gabriele; A G Levis
Journal:  Mutat Res       Date:  1990-06       Impact factor: 2.433

Review 4.  Dicing with death: dissecting the components of the apoptosis machinery.

Authors:  S J Martin; D R Green; T G Cotter
Journal:  Trends Biochem Sci       Date:  1994-01       Impact factor: 13.807

5.  Cell cycle kinetics in human lymphocyte cultures.

Authors:  K Morimoto; S Wolff
Journal:  Nature       Date:  1980-12-11       Impact factor: 49.962

6.  A disease severity scale for systemic sclerosis: development and testing.

Authors:  T A Medsger; A J Silman; V D Steen; C M Black; A Akesson; P A Bacon; C A Harris; S Jablonska; M I Jayson; S A Jimenez; T Krieg; E C Leroy; P J Maddison; M L Russell; R K Schachter; F A Wollheim; H Zacharaie
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

7.  Clastogenic effect of the human T-cell leukemia virus type I Tax oncoprotein correlates with unstabilized DNA breaks.

Authors:  F Majone; K T Jeang
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon.

Authors:  Giovanni Porciello; Roberto Scarpato; Clodoveo Ferri; Franca Storino; Francesca Cagetti; Gabriella Morozzi; Francesca Bellisai; Lucia Migliore; Roberto Marcolongo; Mauro Galeazzi
Journal:  J Rheumatol       Date:  2003-06       Impact factor: 4.666

10.  [The high frequency of spontaneous micronuclei observed in lymphocytes of systemic sclerosis patients: preliminary results].

Authors:  G Porciello; R Scarpato; F Storino; F Cagetti; R Marcolongo; L Migliore; C Ferri; M Galeazzi
Journal:  Reumatismo       Date:  2002
View more
  3 in total

Review 1.  T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.

Authors:  Isabel Almeida; Sara Vieira Silva; Ana Raquel Fonseca; Ivone Silva; Carlos Vasconcelos; Margarida Lima
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

2.  Absolute count of T and B lymphocyte subsets is decreased in systemic sclerosis.

Authors:  Thilo Gambichler; C Tigges; B Burkert; S Höxtermann; P Altmeyer; A Kreuter
Journal:  Eur J Med Res       Date:  2010-01-29       Impact factor: 2.175

3.  Apoptosis modulation as a promising target for treatment of systemic sclerosis.

Authors:  Stéphane Chabaud; Véronique J Moulin
Journal:  Int J Rheumatol       Date:  2011-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.